Lingga, Vanessa G.
HRN: 21-43-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2026
CEFAZOLIN 1GM (VIAL)
01/06/2026
01/07/2026
IV
2grams
Q8h
S/P Repeat CS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes